Huberman LabDr. Tony Wyss-Coray on Huberman Lab: How blood resets aging
Parabiosis cut inflammation in aged mice via young blood factors; blood protein panels now assign organ age gaps that predict disease risk years before.
At a glance
WHAT IT’S REALLY ABOUT
How young-blood factors, exercise signals, and biomarkers reshape aging science
- Dr. Tony Wyss-Coray explains research showing that circulating factors in young blood (and in exercised animals’ blood) can improve brain function in older mice, including reduced inflammation, stem-cell reactivation, and better memory.
- The conversation emphasizes that aging is heterogeneous: organs (and even cell types) age at different rates, and “age gaps” measured from blood proteins can predict future disease risk in specific organs.
- They review early human translation efforts (plasma fractions, therapeutic plasma exchange, small Alzheimer’s/Parkinson’s trials) while repeatedly stressing the need for large, blinded clinical trials and caution against unproven “rejuvenation” clinics.
- Lifestyle pillars—exercise, sleep, light exposure, nutrition/fasting, and social connection—are discussed through the lens of measurable blood/CSF factors and the goal of extending healthspan rather than merely lifespan.
IDEAS WORTH REMEMBERING
5 ideasYoung systemic factors can measurably rejuvenate aged brain function in animals.
In parabiosis and related infusion studies, exposure of old mice to young circulation reduced neuroinflammation, reactivated brain stem-cell activity, increased neural activity measures, and improved memory performance.
Rejuvenation is not just adding “good” factors—removing “bad” ones matters too.
Wyss-Coray describes age-related rises in inflammatory proteins; in mice, neutralizing certain detrimental factors can improve cognition, suggesting therapies may require both supplementation and inhibition.
Aging is organ-specific; an “age gap” in one organ predicts disease risk in that organ.
Using large-scale blood proteomics, proteins originating from specific organs can estimate organ age; deviations from chronological age (“age gap”) strongly predict future disease (e.g., fast-aging heart → higher heart disease risk; fast-aging brain → higher Alzheimer’s risk).
The field is shifting from “one aging clock” to multi-organ and even cell-type aging readouts.
Wyss-Coray previews work assigning plasma proteins to ~40 cell types to estimate cell-type ages; in ALS, “older” skeletal/heart muscle cell signatures predicted future disease risk years before diagnosis.
Human evidence for plasma-based rejuvenation is intriguing but not definitive yet.
Small Alzheimer’s/Parkinson’s infusion studies and a larger Grifols study (therapeutic plasma exchange plus albumin) reported benefits, but the next step is large, blinded, placebo-controlled trials for clear efficacy and approval.
WORDS WORTH SAVING
5 quotesFor the first time, we could take an old brain, and we could give factors from a young organism and ask, ‘Is that going to change the age of the brain?’ And that’s indeed what it did.
— Dr. Tony Wyss-Coray
It’s all of the above.
— Dr. Tony Wyss-Coray
There is no human intervention that can extend lifespan that has been tested or validated.
— Dr. Tony Wyss-Coray
The worst is probably for the body to eat all the time… a lot of people snack the whole day.
— Dr. Tony Wyss-Coray
Alcohol itself is probably not good for our body… but a lot of drinks are part of a social environment.
— Dr. Tony Wyss-Coray
High quality AI-generated summary created from speaker-labeled transcript.
Get more out of YouTube videos.
High quality summaries for YouTube videos. Accurate transcripts to search & find moments. Powered by ChatGPT & Claude AI.
Add to Chrome